Recent Comments
    Current Affairs

    Corona Watch–India–Breakthrough development

    on
    June 30, 2020

    India’s first COVID-19 vaccine candidate COVAXIN gets DCGI (Drug Controller General of India, a Central Govt body) approval for Phase-I and II human trials .

    1.The drug has been developed by Bharat Biotech.

    2. Human clinical trials are scheduled to start across India in July 2020.

    3.The indigenous, inactivated vaccine has been developed and manufactured by Bharat Biotech.

    4. ABOUT BHARAT BIOTECH
    * From the Company’s web link attached below

    4.1.Bharat Biotech International Ltd. is an Indian Biotechnology company, headquartered in Hyderabad, India. 4.2.The company was founded by Indian scientist, Krishna Ella in 1996.
    4.3. Bharat Biotech has one of the largest pharmaceutical manufacturing plants of its kind in Asia-Pacific.
    4.4. It is the first bio-pharma facility in the country to be audited and approved by Korean Food & Drugs Administration (KFDA).
    4.5. It is the First company in the world to launch Cesium Chronicle Free Recombinant Hepatitis-B Vaccine – Revac – Bmcf.
    4.6. The company owns 50 global patents.

    Ramdas Iyer
    30.06.2020
    Tuesday

    Reference Links :

    https://www.cnbctv18.com/healthcare/indias-first-covid-19-vaccine-candidate-covaxin-gets-dcgi-approval-6226931.htm?utm_source=izooto&utm_medium=push_notifications&utm_campaign=India%20s%20vaccine%20candidate&utm_content=&utm_term=

    https://www.ibef.org/industry/biotechnology-india/showcase/bharat-biotech#:~:text=Bharat%20Biotech%20is%20an%20Indian,by%20Indian%20scientist%2C%20Krishna%20Ella.&text=in%20Asia%2DPacific.-,It%20is%20the%20first%20bio%2Dpharma%20facility%20in%20the%20country,)%20at%20Genome%20Valley%2C%20Hyderabad.

    TAGS
    RELATED POSTS

    LEAVE A COMMENT